Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.

Yu-Kwang Donovan, Tay,; Gaia, Tabacco,; Natalie E, Cusano,; John, Williams,; Beatriz, Omeragic,; Rukshana, Majeed,; Almonte, Maximo, Gomez; John P, Bilezikian,; Mishaela R, Rubin,

doi:10.1210/jc.2019-00893

Public

Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.

Published in The Journal of clinical endocrinology and metabolism • Nov 1, 2019

Authors:

Tay, Yu-Kwang Donovan

Tabacco, Gaia

Cusano, Natalie E

Abstract

CONTEXT: Conventional treatment of hypoparathyroidism is associated with decreased renal function and increased bone mineral density (BMD). OBJECTIVE: To evaluate the effects of 8 years of recombinant human parathyroid hormone (1-84) [rhPTH(1-84)] therapy on key biochemical and densitometric indices...

Subject

Adult

Aged

Calcium

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!